SCHEMBL6668035

SCHEMBL6668035

COc1cc(C=Cc2cc(C)[nH]c(=O)n2)ccc1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 11/20 0.66
MMP9 P14780 3/20 0.65
MAPT P10636 3/20 0.56
PTGS2 P35354 3/20 0.56
PRKCE Q02156 2/20 0.56
PRKCQ Q04759 2/20 0.56
PRKCD Q05655 2/20 0.56
CAMK2A Q9UQM7 2/20 0.56
ALOX5 P09917 1/20 0.56
ALOX12 P18054 1/20 0.56
NFKB1 P19838 1/20 0.56
KDR P35968 1/20 0.56
STAT3 P40763 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 1/20 0.56
MEN1 O00255 2/20 0.55
POLB P06746 2/20 0.55
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595479 0.83 KDM4E (0.81) APPMMP9MAPTPTGS2PRKCE
SCHEMBL6595484 0.83 KDM4E (0.81) APPMMP9MAPTPTGS2PRKCE
SCHEMBL7874021 0.79 MMP9 (1.00) APPMMP9MAPTPTGS2PRKCE
SCHEMBL7219703 0.79 MMP9 (1.00) APPMMP9MAPTPTGS2PRKCE
SCHEMBL3396274 0.77 APP (0.74) APPMMP9MAPTPTGS2PRKCE
SCHEMBL671150 0.76 TTR (0.85) APPMMP9MAPTPTGS2PRKCE
SCHEMBL17732299 0.76 TTR (0.85) APPMMP9MAPTPTGS2PRKCE
SCHEMBL671149 0.76 TTR (0.85) APPMMP9MAPTPTGS2PRKCE
SCHEMBL30807100 0.76 TTR (0.85) APPMMP9MAPTPTGS2PRKCE
SCHEMBL10766293 0.74 APP (0.70) APPMMP9MAPTPTGS2PRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO claimed
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO disclosed